Source:http://linkedlifedata.com/resource/pubmed/id/10708987
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2000-4-13
|
pubmed:abstractText |
An SAR model of the induction of mutations at the tk(+/-) locus of L5178Y mouse lymphoma cells (MLA, for mouse lymphoma assay) was derived based upon a re-evaluation of experimental results reported by a Gene-Tox (GT) working group [A.D. Mitchell, A.E. Auletta, D. Clive, P.E. Kirby, M.M. Moore, B.C. Myhr, The L5178Y/tk(+/-) mouse lymphoma specific gene and chromosomal mutation assay. A phase III report of the U.S. Environmental Protection Agency Gene-Tox Program, Mutation Res. 394 (1997) 177-303.]. The predictive performance of the GT MLA SAR model was similar to that of a Salmonella mutagenicity model containing the same number of chemicals. However, the structural determinants (biophores) derived from the GT MLA SAR model include both electrophilic as well as non-electrophilic moieties, suggesting that the induction of mutations in the MLA may occur by both direct interaction with DNA and by non-DNA-related mechanisms. This was confirmed by the observation that the set of biophores associated with MLA overlapped significantly with those associated with phenomena related to loss of heterozygosity, chromosomal rearrangements and aneuploidy. The MLA SAR model derived from the GT data evaluation was significantly more predictive than an SAR model previously derived from MLA data reported by the US National Toxicology Program [B. Henry, S.G. Grant, G. Klopman, H.S. Rosenkranz, Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: evidence for electrophilic and non-electrophilic mechanisms, Mutation Res. 397 (1998) 331-335.]. Moreover, the latter model appeared to be more complex than the former, suggesting that the GT induction data was both simpler mechanistically and more homogeneous than that of the NTP.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0027-5107
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
465
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
201-29
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10708987-Animals,
pubmed-meshheading:10708987-Databases, Factual,
pubmed-meshheading:10708987-Leukemia L5178,
pubmed-meshheading:10708987-Mice,
pubmed-meshheading:10708987-Models, Genetic,
pubmed-meshheading:10708987-Mutagenicity Tests,
pubmed-meshheading:10708987-Mutagens,
pubmed-meshheading:10708987-Mutation,
pubmed-meshheading:10708987-Software,
pubmed-meshheading:10708987-Structure-Activity Relationship,
pubmed-meshheading:10708987-Thymidine Kinase
|
pubmed:year |
2000
|
pubmed:articleTitle |
Modeling the mouse lymphoma forward mutational assay: the Gene-Tox program database.
|
pubmed:affiliation |
Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15238, USA. sgg+@pitt.edu
|
pubmed:publicationType |
Journal Article
|